Speaker Profile

Chief Business Officer, San Diego Blood Bank

Biography
Crane Harris serves as the Chief Business Officer for the San Diego Blood Bank, with responsibility for identifying and leveraging alternative revenue streams to support the SDBB’s core mission. Crane is a business development professional with over 25 years of experience on both the “buy” and “sell” side, working with public and private, large and small, for profit and nonprofit enterprises. He spent the 13 years prior to joining SDBB as Director of Business Development for Illumina, closing many strategic business collaborations, negotiating supply contracts, and supporting the development and launch of new products. He’s received the Values Award, the Pillar Award and the President’s Club awards from Illumina. Prior to Illumina, Crane held leadership positions at La Jolla Pharmaceuticals, Pharmacia/Monsanto Co., and the Environmental Protection Agency (EPA). Crane received his B.A. in Psychology from Vanderbilt University and his M.B.A. at the Darden Business School at the University of Virginia.


Genomic Profiling Showcase:
San Diego Blood Bank

SDBB is a blood center that supports research via cell therapy cleanroom manufacturing and the supply of properly consented biological materials. SDBB is exploring the use of next generation sequencing to enable more precise matching of donor and recipient blood to improve patient outcomes.

Precision Blood™
San Diego Blood Bank is validating an NGS assay to extend typing of blood to better match patients and donors and thereby improve clinical outcomes, especially for patients receiving frequent transfusions such as those with thalassemia, sickle cell, certain cancers.

 Session Abstract – PMWC Silicon Valley


The PMWC 2020 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.